Evaluation of Telemedicine Medical Abortion Service in Ecuador
NCT06270056 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-10-15
Summary
This research seeks to demonstrate that a telemedicine model for the provision of legal abortion services in Ecuador is safe, feasible and acceptable to users requesting a medication abortion and who are less than 12 weeks pregnant.
Conditions
- Pregnancy
Interventions
- DRUG
-
Self-administered misoprostol by clients obtaining medication abortion via telemedicine
Sponsors & Collaborators
-
Gynuity Health Projects
lead OTHER
Principal Investigators
-
Beverly Winikoff, MD, MPH · Gynuity Health Projects
Eligibility
- Min Age
- 15 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-07-24
- Primary Completion
- 2025-07-31
- Completion
- 2025-09-30
Countries
- Ecuador
Study Locations
More Related Trials
-
Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine
NCT02513043 ·Status: COMPLETED
-
Feasibility of Telemedicine Medical Abortion
NCT04599725 ·Status: COMPLETED
-
Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus
NCT02219100 ·Status: COMPLETED ·Phase: NA
-
Chart Review Study of Medical Abortion
NCT02841072 ·Status: COMPLETED
-
Acceptability and Feasibility of a Simplified Medical Abortion Regimen in Georgia
NCT02398838 ·Status: COMPLETED ·Phase: NA
-
Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion
NCT01811056 ·Status: COMPLETED ·Phase: NA
-
Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)
NCT00957346 ·Status: TERMINATED ·Phase: PHASE3
-
Using Telemedicine to Improve Early Medical Abortion at Home
NCT04139382 ·Status: TERMINATED ·Phase: NA
-
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
NCT05028387 ·Status: COMPLETED
-
Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal Misoprostol
NCT00386282 ·Status: COMPLETED ·Phase: NA
-
Telemedicin Counselling for Medical Abortion
NCT03461653 ·Status: COMPLETED ·Phase: NA
-
A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks
NCT02720991 ·Status: COMPLETED ·Phase: PHASE4
-
Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks
NCT05119439 ·Status: TERMINATED ·Phase: PHASE4
-
Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))
NCT00969982 ·Status: COMPLETED ·Phase: NA
-
De-Medicalizing Mifepristone Medical Abortion
NCT00120224 ·Status: COMPLETED
-
Acceptability and Feasibility of Medical Abortion in Singapore
NCT02985229 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in Nepal
NCT05046041 ·Status: COMPLETED ·Phase: PHASE4
-
Research on Equity in Abortion Care by TeleHealth
NCT06787274 ·Status: RECRUITING
-
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Azerbaijan.
NCT05459142 ·Status: COMPLETED
-
Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion
NCT00994734 ·Status: COMPLETED ·Phase: NA
-
Misoprostol for the Treatment of Incomplete Abortion
NCT00670761 ·Status: COMPLETED ·Phase: NA
-
The Extended Gestational Age Medical Abortion Study
NCT00997347 ·Status: COMPLETED ·Phase: PHASE4
-
Medical Termination of II Trimester Pregnancy
NCT03600857 ·Status: COMPLETED ·Phase: PHASE4
-
Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation
NCT01966874 ·Status: COMPLETED
-
Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research
NCT02707653 ·Status: COMPLETED ·Phase: NA